FibroGen (MEX:FGEN) Other Gross PPE : MXN1,277 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is FibroGen Other Gross PPE?

FibroGen's Other Gross PPE for the quarter that ended in Mar. 2024 was MXN1,277 Mil.

FibroGen's quarterly Other Gross PPE increased from Sep. 2023 (MXN1,494 Mil) to Dec. 2023 (MXN3,868 Mil) but then declined from Dec. 2023 (MXN3,868 Mil) to Mar. 2024 (MXN1,277 Mil).

FibroGen's annual Other Gross PPE declined from Dec. 2021 (MXN4,586 Mil) to Dec. 2022 (MXN4,401 Mil) and declined from Dec. 2022 (MXN4,401 Mil) to Dec. 2023 (MXN3,868 Mil).

FibroGen Other Gross PPE Historical Data

The historical data trend for FibroGen's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Other Gross PPE Chart

FibroGen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

3,183.30

3,472.35

4,586.19

4,401.12

3,868.02

FibroGen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															1,718.99	1,564.09	1,493.85	3,868.02	1,276.53

FibroGen Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

FibroGen (MEX:FGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (MEX:FGEN) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

FGEN:USA 0IL8:UK 1FG:Germany

Address

409 Illinois Street, San Francisco, CA, USA, 94158

Website

https://www.fibrogen.com

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.